[
    [
        {
            "time": "2022-01-05",
            "original_text": "Doctor reacts to U.S. travel ban changes",
            "features": {
                "keywords": [
                    "travel ban",
                    "changes"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "transportation",
                    "hospitality"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-01-06",
            "original_text": "Why Protagonist Therapeutics Stock Plunged Today",
            "features": {
                "keywords": [
                    "Protagonist Therapeutics",
                    "plunged"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 9,
                "Duration": 2,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-01-07",
            "original_text": "Rockefeller Foundation President on the call for a ‘COVID charter’ & ending ‘energy poverty’",
            "features": {
                "keywords": [
                    "Rockefeller Foundation",
                    "COVID charter",
                    "energy poverty"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "public health",
                    "energy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Rockefeller Foundation President on the call for a ‘COVID charter’ & ending ‘energy poverty’",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 2,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-01-08",
            "original_text": "LAPD, LAFD members sue over Los Angeles’ vaccine mandate",
            "features": {
                "keywords": [
                    "LAPD",
                    "LAFD",
                    "vaccine mandate",
                    "sue"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "government",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-01-09",
            "original_text": "Early tests show Pfizer’s Covid-19 vaccine for kids ages 5 to 11 is ‘very safe’: Epidemiologist",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Covid-19 vaccine",
                    "kids",
                    "safe"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-01-10",
            "original_text": "India set to get first J&J COVID vaccine doses in October, says source",
            "features": {
                "keywords": [
                    "India",
                    "J&J",
                    "COVID vaccine",
                    "doses"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "international trade"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-01-11",
            "original_text": "15 Best Blue-Chip Stocks to Invest In",
            "features": {
                "keywords": [
                    "Blue-Chip Stocks",
                    "Invest"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "diversified"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2022-01-12",
            "original_text": "10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie",
            "features": {
                "keywords": [
                    "Pharmaceutical Stocks",
                    "Buy",
                    "Lee Ainslie"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-01-13",
            "original_text": "3 reasons why FDA advisors rejected Pfizer’s booster for the general public",
            "features": {
                "keywords": [
                    "FDA",
                    "advisors",
                    "rejected",
                    "Pfizer",
                    "booster"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-01-14",
            "original_text": "FDA Panel Vetoes PFE/BNTX Third Jab for All, Vaccine Stocks Down",
            "features": {
                "keywords": [
                    "FDA Panel",
                    "Vetoes",
                    "PFE/BNTX",
                    "Third Jab",
                    "Vaccine Stocks",
                    "Down"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]